Skip to Content

Rolapitant

Generic Name: rolapitant (roe LA pi tant)
Brand Name: Varubi

Medically reviewed: January 18, 2018

What is rolapitant?

Rolapitant blocks the actions of chemicals in the body that trigger nausea and vomiting.

Rolapitant is used together with other medicines to prevent nausea and vomiting caused by cancer chemotherapy.

Rolapitant may also be used for purposes not listed in this medication guide.

Important Information

Rolapitant can cause a rapid and severe allergic reaction. Tell your doctor if you have a history of allergies to any food or medicines.

Before taking this medicine

You should not use rolapitant if you are allergic to it. This medicine can cause a rapid and severe allergic reaction. Tell your doctor if you have a history of allergies to any food or medicine.

Some medicines can cause unwanted or dangerous effects when used with rolapitant. Your doctor may need to change your treatment plan if you use any of the following drugs:

To make sure rolapitant is safe for you, tell your doctor if you have:

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.

This medicine may affect fertility (your ability to have children) for a short time. Talk to your doctor if you have concerns about this.

It is not known whether rolapitant passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Rolapitant is not approved for use by anyone younger than 18 years old.

How should I use rolapitant?

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Rolapitant is usually given on Day 1 of your chemotherapy treatment, within 2 hours before the start of chemotherapy. Follow your doctor's instructions.

Rolapitant is given either as a tablet taken by mouth, or as an injection infused into a vein. A healthcare provider will give the injection.

You may take rolapitant tablets with or without food.

You should not take rolapitant tablets more than once every 14 days.

Rolapitant injection must be given slowly over at least 30 minutes.

You will be given other medication to prevent nausea or vomiting. Read the medication guide or patient instructions provided with each medication. Do not change your doses or medication schedule without your doctor's advice.

Store the tablets at room temperature away from moisture and heat.

What happens if I miss a dose?

The timing of your rolapitant dose is important for this medicine to be effective. Call your doctor if you forget to take the tablets or you do not receive the injection within 2 hours before your chemotherapy starts.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid after using rolapitant?

For at least 1 month after you use rolapitant, avoid using any cough or cold medicine that contains dextromethorphan. Talk to your doctor about how to best treat a cough due to the common cold.

Rolapitant side effects

Get emergency medical help if you have signs of an allergic reaction: hives, flushing (warmth, redness, or tingly feeling); feeling light-headed; wheezing, chest pain, difficult breathing; back pain, stomach pain, vomiting; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • pain or burning when you urinate;

  • low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet; or

  • low white blood cell counts--fever, swollen gums, painful mouth sores, skin sores, cold or flu symptoms, cough, trouble breathing.

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See also: Side effects (in more detail)

Rolapitant dosing information

Usual Adult Dose for Nausea/Vomiting -- Chemotherapy Induced:

180 mg orally approximately 1 to 2 hours prior to initiation of each chemotherapy cycle.

Comments: Dexamethasone and a 5-HT3 receptor antagonist should be administered concurrently with rolapitant. Consult manufacturer product information for appropriate dosing information for these drugs.

Use: In combination with other antiemetic agents for prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

What other drugs will affect rolapitant?

Other drugs may interact with rolapitant, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using. For at least 28 days after you use rolapitant, it could affect other medicines you are using.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Hide